Tiaki Therapeutics is developing first-in-class therapeutics that target microglia, the immune cells of the brain, to address inflammatory-driven CNS disorders and protect cognitive function.
EveryLife Foundation for Rare Diseases
1 follower
Thermo Fisher Scientific
288 followers
Genentech
227 followers
Gilead Sciences
216 followers
Regeneron
186 followers
Biogen
168 followers
Vertex Pharmaceuticals
115 followers
Agilent Technologies
102 followers
BioMarin Pharmaceutical
60 followers
Alexion Pharmaceuticals
58 followers
Verily Life Sciences
49 followers
Ionis Pharmaceuticals
43 followers